Entry
Name
Epstein-Barr virus infection - Sturnira hondurensis
Description
Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases. EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Sturnira hondurensis [GN:
shon ]
Gene
118981330 LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain-like [KO:K06752 ]
118981732 LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DP alpha 1 chain-like [KO:K06752 ]
118982809 LOW QUALITY PROTEIN: RLA class II histocompatibility antigen, DP alpha-1 chain-like [KO:K06752 ]
118999033 DLA class II histocompatibility antigen, DR-1 beta chain-like isoform X1 [KO:K06752 ]
118999034 HLA class II histocompatibility antigen, DR alpha chain-like [KO:K06752 ]
118999036 SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752 ]
118999037 boLa class II histocompatibility antigen, DQB*0101 beta chain-like isoform X1 [KO:K06752 ]
118991469 HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752 ]
118991472 HLA class II histocompatibility antigen, DM alpha chain isoform X1 [KO:K06752 ]
118991540 LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DO beta chain-like [KO:K06752 ]
118999195 H-2 class II histocompatibility antigen, I-E beta chain-like [KO:K06752 ]
118984928 LOW QUALITY PROTEIN: RLA class II histocompatibility antigen, DP alpha-1 chain-like [KO:K06752 ]
119002380 TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 isoform X1 [KO:K04403 ]
118978986 TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform X1 [KO:K04404 ]
118979949 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
118985299 STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220 ]
118975851 STAT2; signal transducer and activator of transcription 2 [KO:K11221 ]
119001265 EIF2AK2; interferon-induced, double-stranded RNA-activated protein kinase isoform X1 [KO:K16195 ] [EC:2.7.11.1 ]
118987956 FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390 ]
118994764 CD3D; T-cell surface glycoprotein CD3 delta chain isoform X1 [KO:K06450 ]
118979262 CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453 ]
119003765 PSMC5; 26S proteasome regulatory subunit 8 isoform X1 [KO:K03066 ]
118974186 PSMD2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028 ]
118999160 PSMD1; 26S proteasome non-ATPase regulatory subunit 1 isoform X1 [KO:K03032 ]
118978090 PSMD3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033 ]
119003524 PSMD12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035 ]
119003453 PSMD11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036 ]
118983416 PSMD6; 26S proteasome non-ATPase regulatory subunit 6 [KO:K03037 ]
118983790 PSMD7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038 ]
118974903 PSMD13; 26S proteasome non-ATPase regulatory subunit 13 [KO:K03039 ]
118985782 PSMD14; 26S proteasome non-ATPase regulatory subunit 14 [KO:K03030 ]
118976332 PSMD8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031 ]
118996566 ADRM1; proteasomal ubiquitin receptor ADRM1 isoform X1 [KO:K06691 ]
119004008 patr class I histocompatibility antigen, A-2 alpha chain-like isoform X1 [KO:K06751 ]
118980727 H-2 class I histocompatibility antigen, Q9 alpha chain-like [KO:K06751 ]
118980772 patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118996659 class I histocompatibility antigen, Gogo-B*0102 alpha chain-like isoform X1 [KO:K06751 ]
118981397 saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
118981398 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118981399 HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751 ]
118981513 H-2 class I histocompatibility antigen, alpha chain-like [KO:K06751 ]
118981536 HLA class I histocompatibility antigen, alpha chain G-like isoform X1 [KO:K06751 ]
118981733 popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751 ]
118981759 patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118996962 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118997317 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118997319 patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118997469 HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751 ]
118982113 patr class I histocompatibility antigen, A-2 alpha chain-like isoform X1 [KO:K06751 ]
118974354 patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751 ]
118974356 HLA class I histocompatibility antigen, alpha chain E-like [KO:K06751 ]
118974594 popy Class I histocompatibility antigen, A-1 alpha chain-like [KO:K06751 ]
118982708 popy class I histocompatibility antigen, alpha chain E-like isoform X1 [KO:K06751 ]
118974887 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118982813 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118982835 BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751 ]
118982863 class I histocompatibility antigen, Gogo-B*0201 alpha chain-like [KO:K06751 ]
118999075 HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751 ]
118999079 patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751 ]
118999080 HLA class I histocompatibility antigen, alpha chain F-like isoform X1 [KO:K06751 ]
118983746 BOLA class I histocompatibility antigen, alpha chain BL3-7-like [KO:K06751 ]
118991392 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118991570 class I histocompatibility antigen, Gogo-C*0202 alpha chain-like isoform X1 [KO:K06751 ]
118999324 patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118983999 saoe class I histocompatibility antigen, A alpha chain-like isoform X1 [KO:K06751 ]
118984161 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118999599 HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751 ]
118976536 HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751 ]
118992170 class I histocompatibility antigen, Gogo-C*0202 alpha chain-like [KO:K06751 ]
118992194 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118992220 patr class I histocompatibility antigen, A-126 alpha chain-like [KO:K06751 ]
118977201 saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
118977214 patr class I histocompatibility antigen, alpha chain E-like [KO:K06751 ]
118984919 patr class I histocompatibility antigen, A-108 alpha chain-like [KO:K06751 ]
118984920 LOW QUALITY PROTEIN: patr class I histocompatibility antigen, A-108 alpha chain-like [KO:K06751 ]
119000606 saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
118977705 HLA class I histocompatibility antigen, alpha chain F-like [KO:K06751 ]
118993317 popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751 ]
119001579 saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
119001581 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
119002099 HLA class I histocompatibility antigen, B alpha chain-like [KO:K06751 ]
118978534 class I histocompatibility antigen, Gogo-B*0101 alpha chain-like [KO:K06751 ]
118978541 HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751 ]
118978542 patr class I histocompatibility antigen, A-126 alpha chain-like isoform X1 [KO:K06751 ]
118986505 patr class I histocompatibility antigen, B-2 alpha chain-like [KO:K06751 ]
118986617 patr class I histocompatibility antigen, B-2 alpha chain-like [KO:K06751 ]
118994399 popy Class I histocompatibility antigen, A-1 alpha chain-like [KO:K06751 ]
118986866 popy Class I histocompatibility antigen, A-1 alpha chain-like isoform X1 [KO:K06751 ]
118987037 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118987155 patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751 ]
118987156 saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
119002841 class I histocompatibility antigen, Gogo-C*0202 alpha chain-like [KO:K06751 ]
118979575 LOW QUALITY PROTEIN: saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751 ]
118995180 HLA class I histocompatibility antigen, alpha chain E-like [KO:K06751 ]
118985524 RBPJL; recombining binding protein suppressor of hairless-like protein isoform X1 [KO:K06053 ]
118985975 RBPJ; recombining binding protein suppressor of hairless isoform X1 [KO:K06053 ]
118987697 FCER2; low affinity immunoglobulin epsilon Fc receptor isoform X1 [KO:K06468 ]
118984458 GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402 ]
118984673 GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402 ]
118978970 GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402 ]
118997522 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
118986375 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
118982454 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
118975178 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
118998595 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
118999475 NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469 ]
118983883 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1 [KO:K03171 ]
118985558 CD40; tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160 ]
118978208 STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692 ]
118995001 RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392 ]
118983037 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859 ] [EC:3.1.4.11 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Young LS, Rickinson AB.
Title
Epstein-Barr virus: 40 years on.
Journal
Reference
Authors
Saha A, Robertson ES
Title
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
Journal
Reference
Authors
Ning S
Title
Innate immune modulation in EBV infection.
Journal
Reference
Authors
Stanfield BA, Luftig MA
Title
Recent advances in understanding Epstein-Barr virus.
Journal
Reference
Authors
van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME
Title
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
Journal
Reference
Authors
Rajsbaum R, Garcia-Sastre A
Title
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
Journal
Reference
Authors
Hoffmann HH, Schneider WM, Rice CM
Title
Interferons and viruses: an evolutionary arms race of molecular interactions.
Journal
Reference
Authors
Spender LC, Inman GJ
Title
Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
Journal
Reference
Authors
Fu Q, He C, Mao ZR
Title
Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
Journal
Reference
Authors
Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q
Title
The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
Journal
Reference
Authors
Melchjorsen J
Title
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
Journal
Reference
Authors
Hansen TH, Bouvier M
Title
MHC class I antigen presentation: learning from viral evasion strategies.
Journal
Reference
Authors
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ
Title
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Journal
Reference
Authors
Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
Title
Viral evasion of T cell immunity: ancient mechanisms offering new applications.
Journal
Reference
Authors
Ghosh Roy S, Robertson ES, Saha A
Title
Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.
Journal
Reference
Authors
Dawson CW, Port RJ, Young LS
Title
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
Journal
Reference
Authors
Cai Q, Chen K, Young KH
Title
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
Journal
Reference
Authors
Zheng H, Li LL, Hu DS, Deng XY, Cao Y
Title
Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Journal
Cell Mol Immunol 4:185-96 (2007)
Reference
Authors
Ersing I, Bernhardt K, Gewurz BE
Title
NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
Journal
Reference
Authors
Wang LW, Jiang S, Gewurz BE
Title
Epstein-Barr Virus LMP1-Mediated Oncogenicity.
Journal
Reference
Authors
Mori N, Morishita M, Tsukazaki T, Yamamoto N
Title
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Journal
Reference
Authors
Edwards RH, Marquitz AR, Raab-Traub N
Title
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Journal
Reference
Authors
Thorley-Lawson DA
Title
Epstein-Barr virus: exploiting the immune system.
Journal
Reference
Authors
Eliopoulos AG, Young LS
Title
LMP1 structure and signal transduction.
Journal
Reference
Authors
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
Title
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
Journal
Reference
Authors
Kang H, Kiess A, Chung CH
Title
Emerging biomarkers in head and neck cancer in the era of genomics.
Journal
Reference
Authors
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM
Title
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
Journal
Reference
Authors
Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T
Title
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
Journal
Reference
Authors
Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES
Title
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
Journal
Reference
Authors
Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES
Title
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
Journal
Reference
Authors
Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES
Title
Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
Journal
Reference
Authors
Longnecker R
Title
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Journal
Reference
Authors
El-Sharkawy A, Al Zaidan L, Malki A
Title
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.
Journal
Reference
Authors
Dolcetti R, Masucci MG
Title
Epstein-Barr virus: induction and control of cell transformation.
Journal
Reference
Authors
Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
Title
Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
Journal
Related pathway
shon04612 Antigen processing and presentation
shon04620 Toll-like receptor signaling pathway
shon04622 RIG-I-like receptor signaling pathway
KO pathway
LinkDB
All DBs